Nrf2 protects stellate cells from Smad-dependent cell activation

V Prestigiacomo, L Suter-Dick - PloS one, 2018 - journals.plos.org
Hepatic stellate cells (HSC) orchestrate the deposition of extracellular matrix (ECM) and are
the primary effector of liver fibrosis. Several factors, including TGF-β1, PDGF and oxidative …

Orphan nuclear receptor NR4A2 inhibits hepatic stellate cell proliferation through MAPK pathway in liver fibrosis

P Chen, J Li, Y Huo, J Lu, L Wan, B Li, R Gan, C Guo - PeerJ, 2015 - peerj.com
Hepatic stellate cells (HSCs) play a crucial role in liver fibrosis, which is a pathological
process characterized by extracellular matrix accumulation. NR4A2 is a nuclear receptor …

Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis

J Kim, W Kang, SH Kang, SH Park, JY Kim, S Yang… - Scientific reports, 2020 - nature.com
Hepatic fibrogenesis is characterized by activation of hepatic stellate cells (HSCs) and
accumulation of extracellular matrix (ECM). The impact of ECM on TGF-β-mediated …

Endoplasmic reticulum stress in hepatic stellate cells promotes liver fibrosis via PERK-mediated degradation of HNRNPA1 and up-regulation of SMAD2

JH Koo, HJ Lee, W Kim, SG Kim - Gastroenterology, 2016 - Elsevier
Background & Aims Endoplasmic reticulum (ER) stress has been implicated in a variety of
diseases. Hepatic stellate cells (HSCs) contribute to the development of liver fibrosis …

Nrf2 induces lipocyte phenotype via a SOCS3-dependent negative feedback loop on JAK2/STAT3 signaling in hepatic stellate cells

C Lu, W Xu, J Shao, F Zhang, A Chen… - International …, 2017 - Elsevier
Hepatic stellate cells (HSCs) are universally acknowledged to play a core role in the
pathogenesis of hepatic fibrosis. HSCs when activated are characterized by dramatic loss of …

Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling

CT Hung, TH Su, YT Chen, YF Wu, YT Chen, SJ Lin… - Gut, 2022 - gut.bmj.com
Background and objectives Liver fibrosis (LF) occurs following chronic liver injuries.
Currently, there is no effective therapy for LF. Recently, we identified thioredoxin domain …

Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis

M Wang, L Li, Y Xu, J Du, C Ling - Frontiers in pharmacology, 2022 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD) has become one of the most common diseases
and severe problems worldwide because of the global increase in obesity, dyslipidemia …

Inhibitory effect of Sestrin 2 on hepatic stellate cell activation and liver fibrosis

JH Yang, KM Kim, SS Cho, SM Shin, SO Ka… - Antioxidants & redox …, 2019 - liebertpub.com
Aims: Hepatic fibrosis results from chronic liver injury and inflammatory responses. Sestrin 2
(Sesn2), an evolutionarily conserved antioxidant enzyme, reduces the severities of acute …

CDKN2a/p16 antagonizes hepatic stellate cell activation and liver fibrosis by modulating ROS levels

F Lv, N Li, M Kong, J Wu, Z Fan, D Miao… - Frontiers in Cell and …, 2020 - frontiersin.org
The lipid-storage hepatic stellate cells (HSC) play as pivotal role in liver fibrosis being able
to trans-differentiate into myofibroblasts in response to various pro-fibrogenic stimuli. In the …

RNA sequencing of LX-2 cells treated with TGF-β1 identifies genes associated with hepatic stellate cell activation

JP Carson, MW Robinson, GA Ramm… - Molecular Biology …, 2021 - Springer
Abstract Background Hepatic stellate cells (HSCs) are liver-resident myofibroblast
precursors responsible for the production of collagen and maintenance of the hepatic …